Tuberculosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People in Namibia who have been diagnosed with tuberculosis (TB) that is resistant to standard medicines, living in one of three regions: Khomas, Otjozondjupa, or Ohangwena
- People who live in the same household as someone with drug-resistant TB in those regions
- People who have visited someone with drug-resistant TB in hospital in those regions
- People who are members of communities in areas where drug-resistant TB is known to spread easily in those regions
Who may not be able to join:
- Anyone who does not agree to take part in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mareli Claassens, PhD, University of Namibia
Phone: 264814482082
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identification of drug-resistant tuberculosis transmission hotspots in Namibia; Feasibility study of three interventions to enhance drug-resistant TB case finding in Namibia, measured with a questionnaire; Transmission model
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.